FDA issued a Warning Letter to Cispharma Inc. on 7/2/2013 as a result of this inspection.
483 Cispharma Apr 2012

483 Cispharma Apr 2012

Atul Agrawal FDA, Jose Cayuela FDA, Jessica Monteiro FDA$119.00 - Available Now

FDA investigators audited the Cispharma - Cranbury, NJ, United States facility and issued inspectional observations (via FDA 483) on 23 Apr 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 23 Apr 2012
  • Location: Cranbury, United States
  • FEI: 3008276856
Add To Cart